Nimodipine decreases the minimum alveolar concentration of isoflurane in dogs

Nimodipine is a calcium antagonist that binds with high affinity to neuronal membranes. It is a potent cerebrovasodilator and has been demonstrated also to affect neurotransmitter synthesis and release. Because patients undergoing surgery for intracranial aneurysms are frequently receiving nimodipine, the authors determined the MAC of isoflurane in six dogs before and during three infusion doses of nimodipine (0.5, 1.0 and 2.0 μg · kg^-1 · min^-1). MAC was also determined in five dogs before and during infusion of the drug vehicle (10 μl · kg^-1 · min^-1). Nimodipine produced a reduction in MAC from 1.47 ± 0.33% to 1.19 ± 0.18, 1.15 ± 0.18 and 1.15 ± 0.09% during infusions of nimodipine 0.5, 1.0 and 2.0 μg · kg^-1 · min^-1, respectively (P < 0.05). Infusion of drug vehicle alone produced no change in MAC (1.39 ± 0.15%). This reduction in anaesthetic requirement by nimodipine may be due to its effect on neurotransmission. Adjustments in anaesthetic dosage may be necessary in patients receiving nimodipine.